Medical device quality assurance

Recordings from ZEISS Quality Innovation Days.

Stärkt kassa tar Amferia vidare i kampen mot resistenta bakterier

Mölndalsbolaget Amferia har tagit in 1,2 miljoner euro, motsvarande drygt 14 miljoner kronor, för fortsatt utveckling av antibakteriella lösningar som alternati...

ZEISS Quality Innovation Summit video

An event full of experiences, talks, innovations, speeches, and state-of-the-art technology.

Automate E2E Image Analysis Pipelines

ZEISS arivis Pro - Your End-to-End Scientific Image Analysis Software.

ZEISS Quality Innovation Days: April 15 – 19, 2024

Be there when industry experts give exciting insights into different applications and trends in 90 minutes on various theme days.

Rovtidskriftsjägaren om sin ärkefiende: ”Ondskans imperium”

Han myntade begreppet rovtidskrifter och gjorde ett första försök att kartlägga deras utbredning. Nu berättar bibliotekarien Jeffrey Beall om konsekvenserna det...

Lucy Robertshaw: Are we in the perfect storm?

“Is there a perfect storm on the horizon again as elective surgeries were cancelled due to patients being admitted with Covid-19? We now have a long backlog of people who are presenting with chronic diseases that need to access healthcare again”, writes...

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Don't miss ZEISS Quality Innovation Days

Digital event April 15-19, 2024.

Moberg Pharma kapar i ledningsgruppen – ”Naturligt steg”

Som en del av den översyn läkemedelsbolaget Moberg Pharma tidigare kommunicerat krymper deras ledningsgrupp.

Major investment in women’s health – for a more equal healthcare system

”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...

RegSmart Life Science AB

Festo AB

LINK Medical Research

“I am driven by the desire to develop a product that can be sold worldwide”

Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forw...

Newly discovered gene variant linked to protection against abdominal obesity

American researchers believe they have identified a rare gene mutation that protects against abdominal obesity and metabolic syndrome. The ambition is that the ...

Svensk obesitaskandidat visade lovande resultat – ”Kan få stor betydelse”

Tabletten ska främja viktminskning utan att påverka aptit eller muskelmassa. Resultaten är lovande, enligt en klinisk fas I-studie från Karolinska institutet oc...

Läkemedelsbolag skänker nödläkemedel till marburgdrabbade Rwanda

Gilead Sciences har beslutat att skänka 5 000 doser av antivirusläkemedlet remdesivir till Rwanda för nödanvändning under det pågående utbrottet av den fruktade...

BMS satsar på CAR-T-terapi direkt i kroppen

Läkemedelsjätten Bristol Myers Squibb fyller på sin portfölj inom CAR-T-området genom att förvärva biotechbolaget Orbital Therapeutics för 1,5 miljarder dollar,...

Lundbeck behind the first EU-approved intravenous migraine treatment

A preventive, intravenous treatment for migraines has been approved in the EU for the first time.

FHM ska leda expertlabb för ebola och okända virussjukdomar

Folkhälsomyndigheten har fått ansvar för att driva det europeiska referenslaboratoriet för smittsamma sjukdomar som ebola, marburg och rabies. Uppdraget omfatta...

The first vaccine derived from cowpox

The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the ...

FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.